Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT.
Gosewisch A, Schleske M, Gildehaus FJ, Berg I, Kaiser L, Brosch J, Bartenstein P, Todica A, Ilhan H, Böning G. Gosewisch A, et al. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1260-1261. doi: 10.1007/s00259-020-05024-1. Epub 2020 Sep 21. Eur J Nucl Med Mol Imaging. 2021. PMID: 32959113 Free PMC article. No abstract available.
Response to 225Ac-PSMA-I&T after failure of long-term 177Lu-PSMA RLT in mCRPC.
Ilhan H, Gosewisch A, Böning G, Völter F, Zacherl M, Unterrainer M, Bartenstein P, Todica A, Gildehaus FJ. Ilhan H, et al. Among authors: gosewisch a. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1262-1263. doi: 10.1007/s00259-020-05023-2. Epub 2020 Sep 22. Eur J Nucl Med Mol Imaging. 2021. PMID: 32959114 Free PMC article. No abstract available.
Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival.
Rudisile S, Gosewisch A, Wenter V, Unterrainer M, Böning G, Gildehaus FJ, Fendler WP, Auernhammer CJ, Spitzweg C, Bartenstein P, Todica A, Ilhan H. Rudisile S, et al. Among authors: gosewisch a. BMC Cancer. 2019 Aug 8;19(1):788. doi: 10.1186/s12885-019-6000-y. BMC Cancer. 2019. PMID: 31395036 Free PMC article.
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Böning G, Gosewisch A, Wenter V, Unterrainer M, Schmidt-Hegemann N, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H. Zacherl MJ, et al. Among authors: gosewisch a. J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2. J Nucl Med. 2021. PMID: 33008928 Free article.
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours.
Beyer L, Gosewisch A, Lindner S, Völter F, Mittlmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Wenter V, Todica A, Bartenstein P, Ilhan H. Beyer L, et al. Among authors: gosewisch a. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3571-3581. doi: 10.1007/s00259-021-05351-x. Epub 2021 Apr 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 33928401 Free PMC article.
First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics.
Ilhan H, Todica A, Lindner S, Boening G, Gosewisch A, Wängler C, Wängler B, Schirrmacher R, Bartenstein P. Ilhan H, et al. Among authors: gosewisch a. Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2400-2401. doi: 10.1007/s00259-019-04448-8. Epub 2019 Jul 27. Eur J Nucl Med Mol Imaging. 2019. PMID: 31352578 No abstract available.
19 results